Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

With Trump floating tariffs on medicine, suppliers are weighing upgrades, relocation, and, for some, the exit.

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

The moves, announced Monday in the Federal Register, are a precursor to imposing tariffs and threaten to broaden the president’s sweeping US trade war ...

By Oliver Hirt ZURICH (Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in ...

The surge in layoffs comes amidst concerns over the impact of President Donald Trump’s tariffs on the nation’s product ...

In his 13 years as CEO at Amgen, Robert Bradway has seen many of his counterparts at other major biopharma companies come and ...

Novartis NVS shares ended the last trading session 4% higher at $107.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Job Title Sort ascending Business Location Site Date Posted Medical Affairs Lead Regolare, Full time Germany +Alternative Locations Munich (Non-Sales Force) (Novartis Pharma GmbH) Apr 11, 2025 ...

Job Title Sort ascending Business Location Site Date Posted Vodja skupine klinične proizvodnje (m/ž/d) / Senior Manager Clinical Manufacturing (m/f/d) Regulär, Full time Innovative Medicines Slovenia ...